CoronaVac which was approved for emergency use on 20 January. By early March, the country had received 10 million doses of CoronaVac and had vaccinated 4.1 million people. In February, Colombia had purchased 5 million doses and was in talks for an additional 5 million doses, which had been approved for emergency use on 5 February. In February, Ecuador signed a deal for 2 million doses which was approved for emergency use, with the first 1 million doses arrived in early April. In March, Paraguay received a donation of 20,000 doses from Chile. Paraguay began vaccinations with CoronaVac on 10 March. In January, Uruguay purchased 1.75 million doses, of which the first 192,000 doses arrived on 25 February and vaccinations started on 1 March. North America By June 2021, Dominican Republic had received 7.8 million doses of an order for 10 million doses. In March 2021, El Salvador received 1 million doses of a total 2 million dose order for CoronaVac. The immunization campaign was initially focused on teachers, health professionals, firefighters, police, and military personnel. The first doses were provided to public school teachers beginning on March 30, with rollout expanding to private school teachers shortly after. Vaccination of the general public was planned for April 15, after the vaccination of the priority groups. In February 2021, Mexico approved emergency use of CoronaVac. The country had ordered 20 million doses by March 2021, of which 7 million had been received by May. Oceania In March, Fiji said it would be receiving a donation of CoronaVac. Controversies China state media propaganda In January 2021, as part of a misinformation campaign, multiple Chinese state and CCP-affiliated media outlets, including CGTN and the Global Times, have touted CoronaVac and Chinese vaccines as "relatively safer due to their mature technology". Pushing back against concerns of CoronaVac efficacy over the lack of transparency over releasing test results, China state media have raised doubts about the efficacy of the Pfizer–BioNTech vaccine, calling for an investigation into the deaths of elderly people in Norway and Germany after receiving the vaccine. According to Reuters, the reports made allegations of "deliberately downplaying the deaths" and "using propaganda power to promote the Pfizer vaccine and smearing Chinese vaccines". According to a Ming Pao report published on 21 March 2022, of the 1,486 who died of COVID-19 after receiving at least one dose, 1,292 of them or 87%—had gotten the